Fri, Dec 26, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
A SQUARE

Why is investing in wine suited to institutional investors?

Thursday, April 09, 2009
Research that suggests why investing in wine is something institutional investors might want to consider.

A SQUARE :: 09Apr09 Why is investing in wine suited to institutional investors?
Category Wine Investing
Author Sona Blessing
Actively trading the portfolio allows the fund to benefit from the bid/offer spread and relative value/arbitrage plays insulate the fund from pure market risk.
Download this research The many benefits of an A SQUARE subscription Recommend to a friend

<< A SQUARE archive sorted by date    << A SQUARE archive sorted by category

 Article link
More research related to Wine Investing

[25May12] [Wine Investing] A SQUARE 25 May 2012
Investment grade wine – Asset class analysis and fund performance

Download

[05Dec11] [Wine Investing] Empirical research on fine wine performance
The macroeconomic factors determining wine price fluctuations

Download

[29Aug11] [Wine Investing] Investing in fine wine funds
Empirical analysis of fine wine auction prices and performance of wine investment vehicles

Download

[13May10] [Wine Investing] The portfolio diversification benefits of fine wine in economic downturns
Market update, empirical research and recent investment fund performances

Download

[21Sep09] [Wine Investing] A SQUARE: Opportunities in a recovering wine market – Is now the time to invest?
The current prices for fine wine might provide a big investment opportunity

Download

[29Jan09] [Wine Investing] Why now is an opportune time to buy ...
Despite doomsayers prophecies of free falling Grands Crus prices, these wine have held up rather well.

Download

[26Nov08] [Wine Investing] A Wine Fund
Whose performance has held up well through the financial turmoil and has returned +19.46% from Jan.-Oct.’08

Download

[28Aug08] [Wine Investing] Niche Investing in Wine - Champagne
But it is worth bearing in mind that when the general wine market saw a slight softening of price in the latter half of last year - Champagne prices accelerated.

Download

[07May08] [Wine Investing] Wine investing for institutional investors
Traversing the "headline risk" hurdle ...

Download

[13Dec07] [Wine Investing] Wine Investing Expertise
Long-term fundamentals seem to remain in tact because the great Chateaux aren’t making any more wine

Download

[21Aug07] [Wine Investing] The Wine Investment Fund
The fund aims to deliver absolute returns by buying, storing and selling some of the finest wines in the world

Download

[10May07] [Wine Investing] The Vintage Wine Fund
The fund buys top wines - wines 91% top red Bordeaux, stores them to profit from price increases, but also trades actively the bid/ask spreads on such wines

Download

[06Feb07] [Wine Investing] Fine Wine Fund
For their five months and something -8.5% returns

Download

[16Jan07] [Wine Investing] Illi Adato Q & A

Download
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its